Drug Shortage Report for BEXSERO

Last updated on 2018-09-06 History
Report ID 59702
Drug Identification Number 02417030
Brand name BEXSERO
Common or Proper name Multicomponent Meningococcal B Vaccine (recombinant, adsorbed)
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) Recombinant Neisseria meningitidis group B NHBA fusion protein Recombinant Neisseria meningitidis group B NadA protein Recombinant Neisseria meningitidis group B fHBP fusion protein Outer membrane vesicles
Strength(s) 50MCG 50MCG 50MCG 25MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 10's
ATC code J07AH
ATC description BACTERIAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-08-29
Estimated end date 2018-10-05
Actual end date 2018-09-05
Shortage status Resolved
Updated date 2018-09-06
Company comments Supply disruptions may be seen in the private market for packages of 10. Product under allocation. BEXSERO is available in packages of 1.
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-08-31 English Compare
v2 2018-08-31 French Compare
v3 2018-09-05 English Compare
v4 2018-09-05 French Compare
v5 2018-09-06 English Compare